Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract

IU Mysorekar, SJ Hultgren - Proceedings of the National …, 2006 - National Acad Sciences
IU Mysorekar, SJ Hultgren
Proceedings of the National Academy of Sciences, 2006National Acad Sciences
Recurrent urinary tract infections (rUTIs) are a source of considerable morbidity in women.
The infecting bacteria in both rUTIs and a de novo acute infection have been thought to
originate from an extraurinary location. Here, we show in a murine model of UTI that
uropathogenic Escherichia coli (UPEC) established quiescent intracellular reservoirs (QIRs)
in Lamp1+ endosomes within the urinary bladder epithelium. Depending on the integrity of
the urothelial barriers at the time of initial infection, these QIRs were established within …
Recurrent urinary tract infections (rUTIs) are a source of considerable morbidity in women. The infecting bacteria in both rUTIs and a de novo acute infection have been thought to originate from an extraurinary location. Here, we show in a murine model of UTI that uropathogenic Escherichia coli (UPEC) established quiescent intracellular reservoirs (QIRs) in Lamp1+ endosomes within the urinary bladder epithelium. Depending on the integrity of the urothelial barriers at the time of initial infection, these QIRs were established within terminally differentiated superficial facet cells and/or underlying transitional epithelial cells. Treatment of infected bladders harboring exclusively superficial facet cell QIRs with the cationic protein, protamine sulfate, led to epithelial exfoliation and eradication of bacteria in 100% of treated animals. However, when the bacterial QIRs were harbored in underlying transitional cells, stimulation of epithelial turnover triggered reemergence of viable organisms and recurrence of infection. Thus, our results suggest (i) that bacterial QIRs within the bladder may be a previously unappreciated source of recurrent UTIs and (ii) that inducing epithelial exfoliation may be a therapeutic avenue for treating this heretofore recalcitrant disease.
National Acad Sciences